Apria Stock News

INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment, supplies and related services in the United

Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

News of a big acquisition excited investors.

Apria Inc (NASDAQ: APR) spiked 25% after it announced that it had entered a definitive agreement with Owens & Minor (NYSE: OMI) whereby Owens would acquire its common stock shares for $37.50 per shar

Zynga ZNGA +49% Take-Two buys Zynga for $12.7 billion to expand mobile offerings.Apria APR +25% Owens & Minor acquires Apria for $37.50 per share or $1.45B.Molecular Partners…

Owens & Minor, Inc. (NYSE: OMI) announced it is buying Apria, Inc. (Nasdaq: APR) for $1.45 billion. These are the details The post Why Owens & Minor (OMI) Is Buying Apria (APR) For $1.45 Billion appea

The stocks making the biggest moves in premarket trading include Zynga, Lululemon, Apria, and more.

News of a big acquisition excited investors.

(RTTNews) - Owens & Minor, Inc. (OMI) and Apria, Inc. (APR) have entered an agreement, under which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion, as well as the assumption of debt and cash for a total transaction value of approximately $1.6 billion.

The healthcare logistics firm Owens & Minor announced Monday (Jan. 10) it will acquire the home health equipment provider Apria in a transaction worth $1.6 billion.  Owens & Minor President and CEO E

Owens & Minor Inc (NYSE: OMI) has agreed to acquire Apria Inc (NASDAQ: APR) for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. Apria is a pr

Healthcare technology company Owens & Minor Inc. OMI, +2.64% said Monday it has agreed to acquire Apria Inc. APR, -3.54% in a deal with an equity value of about $1.45 billion. Under the terms of the d

Zacks Investment Research downgraded shares of Apria (NYSE:APR) from a buy rating to a hold rating in a research report released on Monday, Zacks.com reports. According to Zacks, Apria Inc. provides integrated home healthcare equipment and related services principally in the United States. It offers home respiratory therapy, obstructive sleep apnea treatment and negative pressure []

Apria, Inc. (NYSE:APR) EVP Angela Fyfe sold 1,719 shares of the firm’s stock in a transaction dated Wednesday, December 22nd. The shares were sold at an average price of $30.52, for a total transaction of $52,463.88. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Angela […]